Clinical Trial Update: Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury [Phase 3]

View source ↗

Summary

Phase 3 trial update on oral fampridine-SR for spasticity in spinal cord injury; safety and efficacy results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasticity
• Spinal Cord Injury

Drugs mentioned

• Fampridine-SR (fampridine)

Snippet

Sponsor: Acorda Therapeutics | Conditions: Spinal Cord Injury, Muscle Spasticity | Phase 3 | Status: COMPLETED | Results posted: 2013-05-31